97925396 - ELEVIDYS

Information

• Trademark
• 97925396

• Source

• Serial Number

  97925396

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  May 08, 2023
  2 years ago

• Transaction Date

  June 05, 2025
  7 months ago

• Status Date

  June 04, 2025
  7 months ago

• Published for Opposition Date

  November 19, 2024
  a year ago

• Location Date

  December 31, 2024
  a year ago

• Status Code

  730

• Current Location

  INTENT TO USE SECTION

  Employee Name

  CHANG, BETTY

• Attorney Name

  Maury M. Tepper, III

  Law Office Assigned Location Code

  M60

• Owners

  • SAREPTA THERAPEUTICS, INC.

Case File Statements

• DM0000: The mark consists of an oval shape comprised of three alternately-shaded curved bands increasing in size to an vesica piscis center and three alternately-shaded curved bands decreasing in size on the other side of the center and followed by "ELEVIDYS".
• GS0051: Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs being pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
• CC0000: Color is not claimed as a feature of the mark.

Case File Event Statements

• 5/11/2023 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 6/6/2023 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 6/7/2023 - 2 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 1/31/2024 - a year ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/31/2024 - a year ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 1/31/2024 - a year ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 4/23/2024 - a year ago

  8 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR

• 4/23/2024 - a year ago

  9 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG

• 1/31/2024 - a year ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 7/25/2024 - a year ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/25/2024 - a year ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/25/2024 - a year ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 10/2/2024 - a year ago

  17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/2/2024 - a year ago

  14 - FINAL REFUSAL E-MAILED Type: GNFR

• 8/2/2024 - a year ago

  15 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 8/2/2024 - a year ago

  13 - FINAL REFUSAL WRITTEN Type: CNFR

• 10/2/2024 - a year ago

  18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/2/2024 - a year ago

  16 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 10/9/2024 - a year ago

  19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/19/2024 - a year ago

  21 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/13/2024 - a year ago

  20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 6/4/2025 - 7 months ago

  25 - SOU EXTENSION 1 FILED Type: EXT1

• 6/4/2025 - 7 months ago

  24 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 6/4/2025 - 7 months ago

  26 - SOU EXTENSION 1 GRANTED Type: EX1G

• 11/19/2024 - a year ago

  22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 12/31/2024 - a year ago

  23 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM